MENU
+Compare
NUVB
Stock ticker: NYSE
AS OF
Jul 3 closing price
Price
$2.09
Change
+$0.04 (+1.95%)
Capitalization
711.15M

NUVB Nuvation Bio Forecast, Technical & Fundamental Analysis

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more

NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NUVB with price predictions
Jul 03, 2025

NUVB's Stochastic Oscillator is staying in overbought zone for 1 day

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

NUVB moved below its 50-day moving average on June 12, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NUVB crossed bearishly below the 50-day moving average on June 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUVB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NUVB's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 27, 2025. You may want to consider a long position or call options on NUVB as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NUVB just turned positive on July 02, 2025. Looking at past instances where NUVB's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NUVB advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .

NUVB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 144 cases where NUVB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.695) is normal, around the industry mean (16.666). P/E Ratio (0.000) is within average values for comparable stocks, (58.763). NUVB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (56.818) is also within normal values, averaging (269.614).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NUVB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUVB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NUVB is expected to report earnings to rise 4.44% to -16 cents per share on August 06

Nuvation Bio NUVB Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Missed
by $1.83
The last earnings report on May 07 showed earnings per share of -15 cents, missing the estimate of -15 cents. With 3.37M shares outstanding, the current market capitalization sits at 711.15M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1500 Broadway
Phone
+1 332 208-6102
Employees
51
Web
https://www.nuvationbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGOVX79.110.87
+1.11%
Hartford Growth Opportunities R6
PAHUX7.150.07
+0.99%
PGIM Jennison NextGeneration Glb Opps Z
RYSPX95.010.79
+0.84%
Rydex S&P 500 H
NGISX17.450.14
+0.81%
Nationwide BNY Mellon Dyn US Core I.S
FIVUX35.920.24
+0.67%
Macquarie Opportunity Instl

NUVB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
+1.95%
BEAM - NUVB
47%
Loosely correlated
+0.65%
ERAS - NUVB
45%
Loosely correlated
-0.69%
XNCR - NUVB
45%
Loosely correlated
+1.45%
DNLI - NUVB
44%
Loosely correlated
-1.41%
KYMR - NUVB
43%
Loosely correlated
+0.58%
More